Battle of the bulge occurs in the liver

June 20, 2014

(Medical Xpress)—An international team of scientists led by Monash University researchers has shown how free radicals contribute to type 2 diabetes, obesity and fatty liver disease.

Type 2 diabetes and non-alcoholic fatty liver disease are key complications of obesity as 80 per cent of patients with are obese, and 75 per cent of patients who are obese or have type 2 diabetes also have fatty liver disease.

The team, led by Professor Tony Tiganis from the Department of Biochemistry and Molecular Biology at Monash, has found that free radical molecules called Reactive Oxygen Species (ROS) wage a battle with enzymes called protein tyrosine phosphatases, initiating a cascade of events with devastating consequences.

The findings, published today in the prestigious journal Cell Metabolism, explain how selective insulin resistance – a pathological feature of type 2 diabetes – occurs in the liver. The study identifies the molecular culprits involved, and reveals how they contribute to disease progression.

"We have shown for the very first time that these inactivate protein tyrosine phosphatases in the liver to activate rogue pathways that promote fatty liver disease and exacerbate the development of obesity and type 2 ," Professor Tiganis said.

Professor Tiganis' team found in lab studies that obesity promoted ROS generation that inactivated a phosphatase called PTPN2. This inactivation in turn exacerbated obesity and fatty progression.

While there is more work to be done to understand the causes of , Professor Tiganis has plans to test two potential therapeutic approaches. One involves inactivating a protein in the liver, and the other will use a selective anti-oxidant to 'mop up' excess free radicals that would otherwise inactivate PTPN2.

While free radicals play important roles in disease, Professor Tiganis advises against taking anti-oxidants indiscriminately.

"Although we need to undertake further studies in humans, preclinical studies indicate that ROS also play important roles in biology," he said.

Explore further: Protein maybe key to halting obesity related disease

Related Stories

Protein maybe key to halting obesity related disease

January 24, 2014
(Medical Xpress)—Australians are getting more obese and developing a disease called non-alcoholic fatty liver disease – a disease similar to that that results in cirrhosis in alcoholics and can be a precursor to diabetes.

Study reverses current thought on treatment of cirrhosis

June 19, 2014
Researchers at Mayo Clinic released a new study reversing current thought on the treatment of cirrhotic patients with type 2 diabetes. The study found that the continuation of metformin after a cirrhosis diagnosis improved ...

Fructose not responsible for increase in non-alcoholic fatty liver disease

February 26, 2014
Non-alcoholic fatty liver disease is the most common chronic liver disease in developed countries, affecting up to 30 per cent of their populations.

Weight loss surgery alters fatty liver disease genes

August 6, 2013
Research has shown that weight loss surgery can benefit obese individuals in ways that go beyond shedding pounds, for example by causing early remission of type 2 diabetes. Now scientists have found that the surgery can also ...

Inflammation in fat tissue helps prevent metabolic disease

June 18, 2014
Chronic tissue inflammation is typically associated with obesity and metabolic disease, but new research from UT Southwestern Medical Center now finds that a level of "healthy" inflammation is necessary to prevent metabolic ...

What what role does MSG play in obesity and fatty liver disease?

May 27, 2014
The commonly used food additive monosodium glutamate (MSG) has been linked to obesity and disorders associated with the metabolic syndrome including progressive liver disease. A new study that identifies MSG as a critical ...

Recommended for you

Scientists find key to regenerating blood vessels

November 23, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.